Epigenetics of Schizophrenia

Abstract

Investigations on gene variants as milestones in the development of schizophrenia have not fulfilled the enormous, initial expectations. Neither candidate gene approaches trying to associate single genes with the disorder, nor genome-wide association studies (GWAS), that have been welcomed more recently with great enthusiasm, could end the general disappointment associated with these strategies. Owing to very large numbers of samples and most advanced sequencing technologies, some variants have been found but their effects, even in combination are very small. In summary, most of the tentative heritability of schizophrenia remains unexplained. More hope to find mechanisms connecting genes with the disorder lies in analyses of the epigenome with technologies developed during the last 10 or 15 years and undergoing more and more refinement recently. Although investigations on interactions between DNA methylation patterns and histone modifications will probably be the greatest challenge in molecular genetics for the next decades, they appear to be the most promising approaches on complex brain disorders that typically show a high dependence on environmental factors.

Key words

schizophrenia - candidate gene approach - genome-wide association studies - expression profiling - epigenetic code - engram

• References

• 1 Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry 2000; 47: 210-220
• 2 McGue M, Gottesman II. The genetic epidemiology of schizophrenia and the design of linkage studies. Eur Arch Psychiatry Clin Neurosci 1991; 240: 174-181
• 3 Crow TJ. “The missing genes: what happened to the heritability of psychiatric disorders?”. Mol Psychiatry 2011; 16: 362-364
• 4 Petronis A. Epigenetics and twins: three variations on the theme. Trends Genet 2006; 22: 347-350
• 5 Niwa M, Matsumoto Y, Mouri A et al. Vulnerability in early life to changes in the rearing environment plays a crucial role in the aetiopathology of psychiatric disorders. Int J Neuropsychopharmacol 2011; 14: 459-477
• 6 Jones SR, Fernyhough C. A new look at the neural diathesis   −   stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations. Schizophr Bull 2007; 33: 1171-1177
• 7 Le Strat Y, Ramoz N, Gorwood P. The role of genes involved in neuroplasticity and neurogenesis in the observation of a gene-environment interaction (GxE) in schizophrenia. Curr Mol Med 2009; 9: 506-518
• 8 Dearry A, Gingrich JA, Falardeau P et al. Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 1990; 347 (6288) 72-76
• 9 Sokoloff P, Giros B, Martres MP et al. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990; 347 (6289) 146-151
• 10 Beischlag TV, Marchese A, Meador-Woodruff JH et al. The human dopamine D5 receptor gene: cloning and characterization of the 5′-flanking and promoter region. Biochemistry 1995; 34: 5960-5970
• 11 Grima B, Lamouroux A, Boni C et al. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 1987; 326 (6114) 707-711
• 12 Kobayashi K, Kurosawa Y, Fujita K et al. Human dopamine beta-hydroxylase gene: two mRNA types having different 3′-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res 1989; 17: 1089-1102
• 13 Fargin A, Raymond JR, Lohse MJ et al. The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 1988; 335 (6188) 358-360
• 14 Chen K, Yang W, Grimsby J et al. The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res Mol Brain Res 1992; 14: 20-26
• 15 Kozasa T, Itoh H, Tsukamoto T et al. Isolation and characterization of the human Gs alpha gene. Proc Natl Acad Sci USA 1988; 85: 2081-2085
• 16 Matsuoka M, Itoh H, Kozasa T et al. Sequence analysis of cDNA and genomic DNA for a putative pertussis toxin-insensitive guanine nucleotide-binding regulatory protein alpha subunit. Proc Natl Acad Sci USA 1988; 85: 5384-5388
• 17 Jones DT, Reed RR. Golf: an olfactory neuron specific-G protein involved in odorant signal transduction. Science 1989; 244 (4906) 790-795
• 18 Glatt K, Glatt H, Lalande M. Structure and organization of GABRB3 and GABRA5. Genomics 1997; 41: 63-69 erratum in: 44: 155
• 19 Furukawa T, Yatsuoka T, Youssef EM et al. Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer. Cytogenet Cell Genet 1998; 82: 156-159
• 20 Seilhamer JJ, Randall TL, Yamanaka M et al. Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 1986; 5: 519-527
• 21 Yoshikawa T, Padigaru M, Karkera JD et al. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2). Mol Psychiatry 2000; 5: 165-171
• 22 Kvajo M, McKellar H, Gogos JA. Molecules, signaling, and schizophrenia. Curr Top Behav Neurosci 2010; 4: 629-656
• 23 Muir WJ, Pickard BS, Blackwood DH. Disrupted-in-Schizophrenia-1. Curr Psychiatry Rep 2008; 10: 140-147
• 24 Costa E, Chen Y, Davis J et al. REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv 2002; 2: 47-57
• 25 Favalli G, Li J, Belmonte-de-Abreu P et al. The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 2011; Oct 25
• 26 Gupta M, Kaur H, Jajodia A et al. Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia. Curr Mol Med 2011; Dec 1
• 27 Guidotti A, Auta J, Davis JM et al. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) 2005; 180: 191-205
• 28 Buonanno A. The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res Bull 2010; 83: 122-131
• 29 Guo AY, Sun J, Riley BP et al. The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry 2009; 14: 18-29
• 30 Souza BR, Souza RP, Rosa DV et al. Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia. Dialogues Clin Neurosci 2006; 8: 95-100
• 31 Mullin AP, Gokhale A, Larimore J et al. Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene. Mol Neurobiol 2011; 44: 53-64
• 32 Collins AL, Kim Y, Sklar P et al. International Schizophrenia Consortium . Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. Psychol Med Aug 2011; 19: 1-10 [Epub ahead of print]
• 33 Shi J, Levinson DF, Duan J et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460 (7256) 753-757
• 34 Stefansson H, Ophoff RA, Steinberg S et al. Common variants conferring risk of schizophrenia. Nature 2009; 460 (7256) 744-747
• 35 Gruen JR, Nalabolu SR, Chu TW et al. A transcription map of the major histocompatibility complex (MHC) class I region. Genomics 1996; 36: 70-85
• 36 Ripke S, Sanders AR, Kendler KS et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976
• 37 Cook EH, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature 2008; 455 (7215) 919-923
• 38 Lee KW, Woon PS, Teo YY et al. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt?. Neurosci Biobehav Rev 2012; 36: 556-571
• 39 Cichon S, Nöthen MM, Stöber G et al. Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 1996; 67: 424-428
• 40 Jacobsen NJ, Franks EK, Owen MJ et al. Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder. Mol Psychiatry 1999; 4: 274-279
• 41 Meszaros K, Lenzinger E, Hornik K et al. Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special?. Psychiatry Res 2000; 96: 179-183
• 42 Van Snellenberg JX, de Candia T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch Gen Psychiatry 2009; 66: 748-755
• 43 Correia SC, Moreira PI. Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?. J Neurochem 2010; 112: 1-12
• 44 Sevrioukova IF. Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid Redox Signal 2011; 14: 2545-2579
• 45 Horton JK, Watson M, Stefanick DF et al. XRCC1 and DNA polymerase beta in cellular protection against cytotoxic DNA single-strand breaks. Cell Res 2008; 18: 48-63
• 46 Lubec B, Labudova O, Hoeger H et al. Expression of transcription factors in the brain of rats with perinatal asphyxia. Biol Neonate 2002; 81: 266-278
• 47 Amé J-C, Spenlehauer C, de Murcia G. The PARP superfamily. BioEssays 2004; 26: 882-893
• 48 Berger NA. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 1985; 100: 4-15
• 49 Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signalling. TIPS 2004; 25: 259-264
• 50 Yu SW, Poitras MF, Coombs C et al. Mediation of poly(ADP-ribose) polymerase-1 dependent cell death by apoptosis-inducing factor. Science 2002; 297: 250-263
• 51 Schmitt A, Leonardi-Essmann F, Durrenberger PF et al. Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study. World J Biol Psychiatry 2011; 12: 201-215
• 52 Sellmann C, Villarín Pildaín L, Schmitt A et al. Differential gene expression in superior temporal cortex of schizophrenia patients. A hypothesis-free evaluation of expression patterns and dynamics. PloS ONE, 2012; submitted
• 53 Griffith M, Griffith OL, Mwenifumbo J et al. Alternative expression analysis by RNA sequencing. Nat Methods 2010; 7: 843-847
• 54 Roth TL, Lubin FD, Sodhi M et al. Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta 2009; 1790: 869-877
• 55 Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010; 465: 721-727
• 56 McCarthy MM, Auger AP, Bale TL et al. The epigenetics of sex differences in the brain. J Neurosci 2009; 29: 12815-12823
• 57 Murgatroyd C, Patchev AV, Wu Y et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 2009; 12: 1559-1566
• 58 Lupien SJ, McEwen BS, Gunnar MR et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009; 10: 434-445
• 59 Ladd-Acosta C, Pevsner J, Sabunciyan S et al. DNA methylation signatures within the human brain. Am J Hum Genet 2007; 81: 1304-1315
• 60 Siegmund KD, Connor CM, Campan M et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One 2007; 2: e895
• 61 Sajikumar S, Navakkode S, Sacktor TC et al. Synaptic tagging and cross-tagging: the role of protein kinase Mzeta in maintaining long-term potentiation but not long-term depression. J Neurosci 2005; 25: 5750-5756
• 62 Shema R, Sacktor TC, Dudai Y. Rapid erasure of long-term memory associations in the cortex by an inhibitor of PKM zeta. Science 2007; 317 (5840) 951-953
• 63 Wood MA, Hawk JD, Abel T. Combinatorial chromatin modifications and memory storage: a code for memory?. Learn Mem 2006; 13: 241-244
• 64 Szyf M, Weaver I, Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol 2007; 24: 9-19
• 65 Tsai HW, Grant PA, Rissman EF. Sex differences in histone modifications in the neonatal mouse brain. Epigenetics 2009; 4: 47-53
• 66 Westberry JM, Prewitt AK, Wilson ME. Epigenetic regulation of the estrogen receptor alpha promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience 2008; 152: 982-989
• 67 Edelmann MN, Auger AP. Epigenetic impact of simulated maternal grooming on estrogen receptor alpha within the developing amygdala. Brain Behav Immun 2011; Feb 23
• 68 Richmond G, Sachs BD. Maternal discrimination of pup sex in rats. Dev Psychobiol 1984; 17: 87-89
• 69 Schwarz JM, Nugent BM, McCarthy MM. Developmental and hormone-induced epigenetic changes to estrogen and progesterone receptor genes in brain are dynamic across the life span. Endocrinology 2010; 151: 4871-4881
• 70 Champagne FA, Weaver IC, Diorio J et al. Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology 2006; 147: 2909-2915
• 71 Weaver IC, Cervoni N et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7: 847-854
• 72 Fischer A, Sananbenesi F, Wang X et al. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007; 447 (7141) 178-182
• 73 Williams BM, Luo Y, Ward C et al. Environmental enrichment: effects on spatial memory and hippocampal CREB immunoreactivity. Physiol Behav 2001; 73: 649-658
• 74 Bruel-Jungerman E, Laroche S, Rampon C. New neurons in the dentate gyrus are involved in the expression of enhanced long-term memory following environmental enrichment. Eur J Neurosci 2005; 21: 513-521
• 75 Champagne DL, Bagot RC, van Hasselt F et al. Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning, and differential responsiveness to glucocorticoids and stress. J Neurosci 2008; 28: 6037-6045
• 76 Levenson JM, Sweatt JD. Epigenetic mechanisms in memory formation. Nat Rev Neurosci 2005; 6: 108-118
• 77 Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007; 128: 669-681
• 78 Bogdanović O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009; 118: 549-565
• 79 Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell 2007; 128: 635-638
• 80 Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705
• 81 Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403 (6765) 41-45
• 82 Borrelli E, Nestler EJ, Allis CD et al. Decoding the epigenetic language of neuronal plasticity. Neuron 2008; 60: 961-974
• 83 Kalkhoven E. CBP and p300: HATs for different occasions. Biochem Pharmacol 2004; 68: 1145-1155
• 84 Korzus E, Rosenfeld MG, Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 2004; 42: 961-972
• 85 Grayson DR, Chen Y, Costa E et al. The human reelin gene: transcription factors (+), repressors (  −  ) and the methylation switch (+/  −  ) in schizophrenia. Pharmacol Ther 2006; 111: 272-286
• 86 Abdolmaleky HM, Cheng KH, Faraone SV et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006; 15: 3132-3145
• 87 Abdolmaleky HM, Cheng KH, Russo A et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 134B: 60-66
• 88 Maliszewska-Cyna E, Bawa D, Eubanks JH. Diminished prevalence but preserved synaptic distribution of N-methyl-D-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain. Neuroscience 2010; 168: 624-632
• 89 Moretti P, Zoghbi HY. MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 2006; 16: 276-281
• 90 Peleg S, Sananbenesi F, Zovoilis A et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010; 328 (5979) 753-756
• 91 Nicodemus KK, Marenco S, Batten AJ et al. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry 2008; 13: 873-877
• 92 Mehler MF, Mattick JS. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev 2007; 87: 799-823
• 93 Kosik KS. The neuronal microRNA system. Nat Rev Neurosci 2006; 7: 911-920
• 94 Ashraf SI, Kunes S. A trace of silence: memory and microRNA at the synapse. Curr Opin Neurobiol 2006; 16: 535-539
• 95 Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002; 71: 817-846
• 96 Valente L, Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol 2005; 79: 299-338
• 97 Mattick JS, Mehler MF. RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci 2008; 31: 227-233
• 98 Lai F, Chen CX, Lee VM et al. Dramatic increase of the RNA editing for glutamate receptor subunits during terminal differentiation of clonal human neurons. J Neurochem 1997; 69: 43-52